• Explore /
  • Poster
  • / Chemotherapy rechallenge or reintroduction (CTr/r), regofenib (REG) and TAS-102 for metastatic pretreated colorectal cancer (mCRC) patients (pts): A propensity score analysis of treatment beyond second-line (PROSERpINA Study).

Chemotherapy rechallenge or reintroduction (CTr/r), regofenib (REG) and TAS-102 for metastatic pretreated colorectal cancer (mCRC) patients (pts): A propensity score analysis of treatment beyond second-line (PROSERpINA Study).

Abstract Poster

Authors

null

Maria Alessandra Calegari

Oncologia Medica, Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, Roma, Italy

Maria Alessandra Calegari , Ina Valeria Zurlo , Michele Basso , Armando Orlandi , Maria Bensi , Floriana Camarda , Brunella Di Stefano , Raffaella Vivolo , Carmelo Pozzo , Isabella Sperduti , Emilio Bria , Lisa Salvatore , Giampaolo Tortora

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3556)

DOI

10.1200/JCO.2019.37.15_suppl.3556

Abstract #

3556

Poster Bd #

48

Abstract Disclosures

Similar Posters

First Author: Mahjabeen Fatima Iqbal

First Author: Le-chi Ye

First Author: Hiroyuki Uetake

First Author: Angelique Vienot